High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer

References

1. ↵
   1. Manz DH,
   2. Blanchette NL,
   3. Paul BT,
   4. Torti FM,
   5. Torti SV

   (2016) Iron and cancer: recent insights. Annals of the New York Academy of Sciences 1368:149–161.

   OpenUrl
2. ↵
   1. Urano S,
   2. Ohara T,
   3. Noma K,
   4. Katsube R,
   5. Ninomiya T,
   6. Tomono Y,
   7. et al.

   (2016) Iron depletion enhances the effect of sorafenib in hepatocarcinoma. Cancer Biol Ther 17:648–656.

   OpenUrl
3. ↵
   1. Li Z,
   2. Tanaka H,
   3. Galiano F,
   4. Glass J

   (2011) Anticancer activity of the iron facilitator LS081. J Exp Clin Cancer Res 30:34.

   OpenUrlCrossRefPubMed
4. ↵
   1. Alkhateeb AA,
   2. Connor JR

   (2013) The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta 1836:245–254.

   OpenUrl
5. ↵
   1. Chekhun VF,
   2. Lukyanova NY,
   3. Burlaka CA,
   4. Bezdenezhnykh NA,
   5. Shpyleva SI,
   6. Tryndyak VP,
   7. et al.

   (2013) Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin. Int J Oncol 43:1481–1486.

   OpenUrl
6. ↵
   1. Alkhateeb AA,
   2. Leitzel K,
   3. Ali SM,
   4. Campbell-Baird C,
   5. Evans M,
   6. Fuchs EM,
   7. et al.

   (2012) Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PloS One 7:e51379.

   OpenUrlCrossRefPubMed
7. ↵
   1. Carpagnano GE,
   2. Lacedonia D,
   3. Palladino GP,
   4. Koutelou A,
   5. Martinelli D,
   6. Orlando S,
   7. et al.

   (2012) Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? Eur J Clin Invest 42:478–486.

   OpenUrlPubMed
8. 1. Shi HB,
   2. Li XD,
   3. Jiang JT,
   4. Zhao WQ,
   5. Ji M,
   6. Wu CP

   (2014) Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy. J Cancer Res Ther 10:681–685.

   OpenUrl
9. ↵
   1. Ji M,
   2. Li XD,
   3. Shi HB,
   4. Ning ZH,
   5. Zhao WQ,
   6. Wang Q,
   7. et al.

   (2014) Clinical significance of serum ferritin in elderly patients with primary lung carcinoma. Tumour Biol 35:10195–10199.

   OpenUrl
10. ↵
    1. Kalousova M,
    2. Krechler T,
    3. Jachymova M,
    4. Kubena AA,
    5. Zak A,
    6. Zima T

    (2012) Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study. Tumour Biol 33:1695–1700.

    OpenUrlPubMed
11. ↵
    1. Wang SL,
    2. Cao S,
    3. Wu R,
    4. Chi F,
    5. Tang MY,
    6. Jin XY,
    7. et al.

    (2015) Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer. Future Oncol 11:2905–2910.

    OpenUrl
12. ↵
    1. Strasser-Weippl K,
    2. Ludwig H

    (2014) Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantation. Leuk Lymphoma 55:2520–2524.

    OpenUrl
13. ↵
    1. Facciorusso A,
    2. Del Prete V,
    3. Antonino M,
    4. Neve V,
    5. Crucinio N,
    6. Di Leo A,
    7. et al.

    (2014) Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation. J Gastroenterol Hepatol 29:1905–1910.

    OpenUrl
14. ↵
    1. Morgenstern DA,
    2. London WB,
    3. Stephens D,
    4. Volchenboum SL,
    5. Simon T,
    6. Nakagawara A,
    7. et al.

    (2016) Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database. Eur J Cancer 65:1–10.

    OpenUrl
15. ↵
    1. Lee S,
    2. Song A,
    3. Eo W

    (2016) Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer. J Cancer 7:957–964.

    OpenUrl
16. ↵
    1. Bouwhuis MG,
    2. Collette S,
    3. Suciu S,
    4. de Groot ER,
    5. Kruit WH,
    6. Ten Hagen TL,
    7. et al.

    (2011) Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-alpha (EORTC 18952) and prognostic value on treatment outcome. Melanoma Research 21:344–351.

    OpenUrlPubMed
17. ↵
    1. Petekkaya I,
    2. Aksoy S,
    3. Roach EC,
    4. Okoh AK,
    5. Gecmez G,
    6. Gezgen G,
    7. et al.

    (2014) Impact of inflammatory markers on the prognosis of patients with operable breast cancer. J BUON 19:673–680.

    OpenUrl
18. ↵
    1. Kim KS,
    2. Son HG,
    3. Hong NS,
    4. Lee DH

    (2012) Associations of serum ferritin and transferrin % saturation with all-cause, cancer, and cardiovascular disease mortality: Third National Health and Nutrition Examination Survey follow-up study. J Prev Med Public Health 45:196–203.

    OpenUrlCrossRefPubMed
19. ↵
    1. Chua AC,
    2. Knuiman MW,
    3. Trinder D,
    4. Divitini ML,
    5. Olynyk JK

    (2016) Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes. Am J Clin Nutr 104:736–742.

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Giessen-Jung C,
    2. Nagel D,
    3. Glas M,
    4. Spelsberg F,
    5. Lau-Werner U,
    6. Modest DP,
    7. et al.

    (2015) Preoperative serum markers for individual patient prognosis in stage I-III colon cancer. Tumour Biol 36:7897–7906.

    OpenUrl
21. ↵
    1. Giessen C,
    2. Nagel D,
    3. Glas M,
    4. Spelsberg F,
    5. Lau-Werner U,
    6. Modest DP,
    7. et al.

    (2014) Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer. Tumour Biol 35:10237–10248.

    OpenUrlCrossRefPubMed
22. ↵
    1. Buranrat B,
    2. Connor JR

    (2015) Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death. Oncology Reports 34:2790–2796.

    OpenUrl
23. ↵
    1. Chekhun SV,
    2. Lukyanova NY,
    3. Shvets YV,
    4. Burlaka AP,
    5. Buchinska LG

    (2014) Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells. Exp Oncol 36:179–183.

    OpenUrl
24. ↵
    1. Usnarska-Zubkiewicz L,
    2. Strutynska-Karpinska M,
    3. Zubkiewicz-Kucharska A,
    4. Zarebski P,
    5. Grabowski K

    (2014) Soluble urokinase-type plasminogen activator receptor and ferritin concentration in patients with advanced alimentary tract carcinoma. Relationship to localization, surgical treatment and the stage of the disease--preliminary report. Adv Clin Exp Med 23:959–967.

    OpenUrl
25. ↵
    1. Prutki M,
    2. Poljak-Blazi M,
    3. Jakopovic M,
    4. Tomas D,
    5. Stipancic I,
    6. Zarkovic N

    (2006) Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Letters 238:188–196.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Ma Y,
    2. Zhao M,
    3. Zhong J,
    4. Shi L,
    5. Luo Q,
    6. Liu J,
    7. et al.

    (2010) Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer. J Cell Biochem 110:1512–1519.

    OpenUrlCrossRefPubMed
27. ↵
    1. Jezequel P,
    2. Campion L,
    3. Spyratos F,
    4. Loussouarn D,
    5. Campone M,
    6. Guerin-Charbonnel C,
    7. et al.

    (2012) Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study. Int J Cancer 131:426–437.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    1. Alkhateeb AA,
    2. Han B,
    3. Connor JR

    (2013) Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat 137:733–744.

    OpenUrlCrossRef
29. ↵
    1. Tesfay L,
    2. Huhn AJ,
    3. Hatcher H,
    4. Torti FM,
    5. Torti SV

    (2012) Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells. PloS One 7:e40030.

    OpenUrlCrossRefPubMed